Schrodinger (NASDAQ:SDGR - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Wednesday, July 30th. Analysts expect the company to announce earnings of ($0.83) per share and revenue of $52.03 million for the quarter. Schrodinger has set its FY 2025 guidance at EPS.
Schrodinger (NASDAQ:SDGR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrodinger had a negative net margin of 83.39% and a negative return on equity of 44.74%. The company had revenue of $59.55 million during the quarter, compared to analyst estimates of $54.60 million. During the same quarter last year, the business posted ($0.86) EPS. The firm's revenue for the quarter was up 62.7% on a year-over-year basis. On average, analysts expect Schrodinger to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Schrodinger Trading Down 1.2%
Schrodinger stock traded down $0.26 during trading on Friday, hitting $22.23. The company had a trading volume of 760,915 shares, compared to its average volume of 1,023,301. Schrodinger has a 1-year low of $16.60 and a 1-year high of $28.47. The company's 50 day simple moving average is $21.83 and its 200-day simple moving average is $22.49. The stock has a market cap of $1.63 billion, a price-to-earnings ratio of -8.45 and a beta of 1.58.
Institutional Investors Weigh In On Schrodinger
A hedge fund recently raised its stake in Schrodinger stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 4.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 33,055 shares of the company's stock after purchasing an additional 1,412 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Schrodinger were worth $653,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. Morgan Stanley started coverage on shares of Schrodinger in a research note on Thursday, July 3rd. They issued an "equal weight" rating and a $28.00 price target for the company. KeyCorp decreased their price objective on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a research note on Monday, July 14th.
View Our Latest Research Report on Schrodinger
About Schrodinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Recommended Stories

Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.